Skip to main content

Table 3 Postoperative characteristics of patients among two groups

From: The effect of neostigmine on postoperative delirium after colon carcinoma surgery: a randomized, double-blind, controlled trial

  Group N
(n = 196)
Group P
(n = 205)
P-value
POD, n (%) 38(19.39%) 43(20.98%) 0.692
POD duration n, (%)    0.928
 Non-POD n, (%) 158(80.61%) 162(79.02%)  
 0 to 6 h n, (%) 22(11.22%) 26(12.68%)  
 6 to 12 h n, (%) 9(4.59%) 11(5.37%)  
 > 12 h n, (%) 7(3.57%) 6(2.93%)  
Postoperative MDAS score (point, \(\overline x\) ± s) 8.17 ± 3.44 8.36 ± 3.37 0.571
Postoperative 24 h NRS score (point, \(\overline x\) ± s) 1.98 ± 1.29 2.06 ± 1.22 0.505
Abnormal muscle weakness, n (%) 0(0%) 0(0%)  
PONV, n (%) 24(12.24%) 22(10.73%) 0.635
Gastrointestinal complications, n (%) 35(17.86%) 48(23.41%) 0.170
Wound bleeding and infection, n (%) 13(6.63%) 17(8.29%) 0.528
POPCs, n (%) 42(21.43%) 63(30.73%) 0.034*
Cardiac complications, n (%) 3(1.53%) 2(0.98%) 0.679
Cerebrovascular complications, n (%) 1(0.51%) 2(0.98%) 1.000
Postoperative hospital stay (day, \(\overline x\) ± s) 12.44 ± 2.78 12.54 ± 2.50 0.726
Mortality in 6 months, n (%) 3(1.53%) 4(1.96%) 1.000
  1. Abbreviation: PONV Postoperative nausea and vomiting, POPCs Postoperative pulmonary complications
  2. *P < 0.05 in comparison with group P